Protein A Beads

Details zu Produkt Nr. ABIN921275, Anbieter: Anmelden zum Anzeigen
Antigen
  • alpha protein
  • repB
Reaktivität
Staphylococcus aureus (S. aureus)
Applikation
Separation (Sep), Purification (Purif)
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Request

Dieses Produkt umsonst

Schicken Sie uns Ihren Validierungsvorschlag. Ich möchte dieses Produkt validieren

Mehr erfahren

Verwendungszweck Protein A Beads for affinity purification of antibodies.
Spezifität Protein A binds to most human and mouse IgG subclasses (e.g. human IgG1, IgG2, IgG3, IgG4, IgA, mouse IgG1, IgG2a, IgG2b, IgG3). It also binds to rat IgG1, IgG2c, goat IgG1, IgG2, sheep IgG1, IgG2, cow IgG1, IgG2, horse IgG (ab), IgG(c). Protein A binds strongly to total IgG from rabbit, dog, cat, pig, guinea pig.
Produktmerkmale Protein A Beads Specifications
Matrix: CNBr-activated SepharoseTM 4FF.
Beads concentration: 1-2 mg/ml.
Coupling conditions of matrix: pH 7-9, 4°C to 25°C, 2-16 h.
Binding capacity: 4-7 mg IgG per ml.
Bead size range: 45-165 m.
Mean bead size: 90 m.
Bead structure: Highly cross-linked agarose, 4%.
Max. flow rate: 4 ml/min/cm2.
Recommended flow rate: 1-3 ml/min/cm2.
Stability of the matrix: pH 3-11 (ligand dependent).
ProductDetails: Bead Ligand Protein A
ProductDetails: Bead Matrix Sepharose beads
ProductDetails: Bead Size 90 µm
Applikationshinweise This product can be used for 100-200 times. For frequent use, an aliquot can be stored at 4ºC for 1 month with addition of 0.02% sodium azide (NaN3) to the storage buffer. Because this product can purify IgG subclasses from several species of mammals.
Aufbereitung der Reagenzien

Buffers preparation: Equilibration buffer A: 1% Nacl+0.1% Na 2HPO4, pH7.5. Equilibration buffer B: 1% CH3COONa adjusted pH to 5 by CH3COOH. Elution buffer: 2% table sugar adjusted pH to 2-3 by CH3COOH. Wash buffer: purified water. Storage buffer: 30% glycerol.

Aufbereitung der Proben

Sample preparation: 1. Dilute the serum with equilibration buffer A to ensure its content and pH closed to equilibration buffer A. 2. Centrifuge diluted serum supernatants to sediment debris. 3. Filter supernatants through 0.45m filter.

Testdurchführung

Affinity-purification: 1. Load the Protein A beads into the empty column. 2. Wash column with Wash buffer in 3-5 column volumes to remove the glycerol, and then, equilibrate column by washing with Equilibration buffer A in 5-10 column volumes. 3. Bring the sample to room temperature, and load it into the column by a syringe or a pump. The total volume of the sample applied is not critical in most cases. 4. Load the sample into the column and collect the flow liquid, repeat this action for 3-5 times. If necessary, repeat for more times, then deal with the collected liquid reasonably. 5. Wash the column with Equilibration buffer B to remove other proteins. 6. Elute with Elution buffer, collect the flow liquid (antibody), adjust its pH by saturated Na2CO3 during collection. Then, customers can test the related data of the antibody as their own requirements. Re-equilibration and Storage: 1. Add 5-10ml Elution buffer to column to elute thoroughly, then neutralizate the column with Equilibration buffer A. 2. Wash the column bed with Storage buffer in 3-5 column volumes, seal the bottom of the column and store at -20°C for at least one year. For frequent use, an aliquot can be stored at 4°C for 1 month with addition of 0.02% sodium azide (NaN 3) to the storage buffer.

Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1-2 mg/mL
Buffer Equilibration buffer A: 1% NaCl+0.1% Na2HPO4 , pH 7.5
Equilibration buffer B: 1% CH3COONa adjusted pH to 5 by CH3COOH
Elution buffer: CH3COOH (pH 2-3) or 0.1mol Glycine Hydrochlorde.
Wash buffer: 1% NaCl+0.1% Na2HPO4, pH 7.5
Storage buffer: 30% glycerol
Handhabung Note: 20% ethanol was contained as protection solution in this product, please wipe off the ethanol before use.
Lagerung 4 °C/-20 °C
Informationen zur Lagerung At -20°C for at least one year. Store at 4°C for frequent use.
Allgemeine Veröffentlichungen Yu, Fang, Zhu, Wang, Tien, Zhang, Chen: "One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge." in: Vaccine, Vol. 28, Issue 9, pp. 2088-96, 2010 (PubMed).